Search research articles
Contact Us
Filters
Showing results (131-140 of 166) with videos related to
Page
of 17
Sort By:
Cancer
|
December 3, 2016
Clinicopathological features and clinical outcomes associated with TP53 and BRAF<sup>N</sup><sup>on-</sup><sup>V</sup><sup>600</sup> mutations in cutaneous melanoma patients
Dae Won Kim, Lauren E Haydu, Aron Y Joon, et al.
Molecular Cancer Therapeutics
|
November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4
Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
JAMA Oncology
|
May 1, 2018
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome
Kyle Chang, Melissa W Taggart, Laura Reyes-Uribe, et al.
Cancer Immunology Research
|
March 4, 2017
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
Haley L Peters, Satyendra C Tripathi, Celine Kerros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Clinical Genitourinary Cancer
|
August 7, 2021
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Cancer Cell
|
October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Leng Han, Lixia Diao, Shuangxing Yu, et al.
Nature Communications
|
September 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responses
Minying Zhang, Jens Fritsche, Jason Roszik, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 166) with videos related to
Sort By:
Page
of 17
Cancer
|
December 3, 2016
Clinicopathological features and clinical outcomes associated with TP53 and BRAF<sup>N</sup><sup>on-</sup><sup>V</sup><sup>600</sup> mutations in cutaneous melanoma patients
Dae Won Kim, Lauren E Haydu, Aron Y Joon, et al.
Molecular Cancer Therapeutics
|
November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4
Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
JAMA Oncology
|
May 1, 2018
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome
Kyle Chang, Melissa W Taggart, Laura Reyes-Uribe, et al.
Cancer Immunology Research
|
March 4, 2017
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
Haley L Peters, Satyendra C Tripathi, Celine Kerros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Clinical Genitourinary Cancer
|
August 7, 2021
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Cancer Cell
|
October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Leng Han, Lixia Diao, Shuangxing Yu, et al.
Nature Communications
|
September 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responses
Minying Zhang, Jens Fritsche, Jason Roszik, et al.
ESMO Open
|
October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Aparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
Page
of 17